CAS 1393124-08-7

Fórmula: C26H28F3N3O4

InChI: InChI=1S/C26H28F3N3O4/c1-4-5-22(18-6-8-19(9-7-18)25(35)30-11-10-23(33)34)36-21-12-16(2)24(17(3)13-21)32-15-20(14-31-32)26(27,28)29/h6-9,12-15,22H,4-5,10-11H2,1-3H3,(H,30,35)(H,33,34)/t22-/m0/s1

Clave InChI: IBDYYOQKQCCSDP-QFIPXVFZSA-N

SMILES: CCC[C@@H](C1=CC=C(C=C1)C(=O)NCCC(=O)O)OC2=CC(=C(C(=C2)C)N3C=C(C=N3)C(F)(F)F)C

PF-06291874

CAS: 1393124-08-7

PF-06291874

Fórmula: C₂₆H₂₈F₃N₃O₄

Pureza: ≥98%

Peso molecular: 503.51

Ref: 54-BUP16360

glucagon receptor antagonists-4

CAS: 1393124-08-7

Fórmula: C₂₆H₂₈F₃N₃O₄

Pureza: %

Forma y color: Solid

Peso molecular: 503.5134

Ref: IN-DA009CML

Glucagon Receptor Antagonists-4

CAS: 1393124-08-7

Glucagon Receptor Antagonists-4

Fórmula: C₂₆H₂₈F₃N₃O₄

Pureza: 98+%

Peso molecular: 503.51342

Ref: 54-BISN0020

PF-06291874

CAS: 1393124-08-7

(S)-3-(4-(1-(3,5-Dimethyl-4-(4-(trifluoromethyl)-1H-pyrazol-1-yl)phenoxy)butyl)benzamido)propanoic acid

Fórmula: C₂₆H₂₈F₃N₃O₄

Pureza: 98+%

Peso molecular: 503.51

Ref: IN-DG571752

PF-06291874

CAS: 1393124-08-7

PF-06291874 (Glucagon receptor antagonists-4) (Glucagon receptor antagonists-4) is a highly effective and orally active antagonist of the glucagon receptor.

Fórmula: C₂₆H₂₈F₃N₃O₄

Pureza: 99.12% - 99.27%

Forma y color: White Solid

Peso molecular: 503.5134

Ref: TM-TQ0239

PF-06291874

CAS: 1393124-08-7

PF-06291874 is a monoclonal antibody that binds to the active form of glucagon-like peptide 1 (GLP-1) and inhibits its degradation by dipeptidyl peptidase IV. PF-06291874 is orally administered and has been shown in clinical trials to significantly reduce blood glucose levels in patients with type 2 diabetes. It has also been shown to have pharmacokinetic properties that are different from other GLP-1 receptor agonists, which may allow it to be used as an antidiabetic agent for diabetic patients who cannot use other oral agents.

Fórmula: C₂₆H₂₈F₃N₃O₄

Pureza: Min. 95%

Peso molecular: 503.51 g/mol

Ref: 3D-TFC12408